Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (Q3842893): Difference between revisions
From MaRDI portal
Set OpenAlex properties. |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: A Two-Stage Procedure for Survival Studies with Surrogate Endpoints / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Using surrogate failure time data to increase cost effectiveness in clinical trials / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: A Stochastic Model for Censored-Survival Data in the Presence of an Auxiliary Variable / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Inference using surrogate outcome data and a validation sample / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Analyzing survival data in conjunction with time-dependent surrogate endpoints in clinical trials / rank | |||
Normal rank | |||
Latest revision as of 14:53, 28 May 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials |
scientific article |
Statements
Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (English)
0 references
30 June 1999
0 references
conditional independence
0 references
exponential components
0 references
colorectal adjuvant clinical trials
0 references
